Herbs (Global Traditional) · Traditional Chinese Medicine
Heartleaf (Houttuynia cordata) (Houttuynia cordata)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Heartleaf (Houttuynia cordata) contains quercetin and chlorogenic acid as primary bioactive compounds that modulate inflammatory pathways. These compounds work primarily by inhibiting NF-κB signaling and suppressing proinflammatory cytokine production.
Heartleaf (Houttuynia cordata) is a perennial herbaceous plant native to East Asia, including China, Japan, Korea, and parts of Southeast Asia, belonging to the Saururaceae family. The whole plant (aerial parts and roots) is traditionally extracted via decoction, hot water infusion, ethanol, or supercritical CO2 methods to yield bioactive extracts rich in flavonoids, polysaccharides, and volatile oils.
Currently, no human clinical trials, RCTs, or meta-analyses are available in the research literature. Evidence is limited to preclinical in vitro and in vivo animal studies, including mouse models showing polysaccharides at 40 mg/kg/day improved survival in H1N1 infection and flavonoid glycosides reduced lung inflammation.
No clinically studied human dosages are established. Animal studies used 50-200 mg/kg oral doses of supercritical extract in rats and 40 mg/kg/day of polysaccharides in mice. Consult a healthcare provider before starting any new supplement.
Heartleaf (Houttuynia cordata) is primarily consumed as a medicinal herb and vegetable (especially in Southeast Asian cuisine), with the following characterized composition per 100g fresh weight: Macronutrients: Protein ~2.0–2.5g, Carbohydrates ~4.0–5.0g, Dietary fiber ~1.5–2.0g, Fat ~0.5g, Moisture ~85–90g, Calories approximately 25–30 kcal. Key Micronutrients: Potassium ~300–350mg, Calcium ~70–100mg, Magnesium ~20–30mg, Iron ~2–3mg, Zinc ~0.5–1.0mg, Phosphorus ~40–60mg, Vitamin C ~25–30mg (moderate bioavailability), Vitamin A precursors (beta-carotene) ~500–800 µg RAE. Primary Bioactive Compounds: (1) Decanoyl acetaldehyde (decanal) — the principal volatile constituent (~0.1–1.0% of essential oil), responsible for characteristic fishy odor and demonstrated antimicrobial activity; (2) Quercetin and Quercitrin (quercetin-3-rhamnoside) — flavonoids present at ~50–200mg/100g dry weight, with moderate oral bioavailability (~20–30% after intestinal metabolism); (3) Rutin ~10–50mg/100g dry weight; (4) Isoquercitrin; (5) Hyperoside; (6) Chlorogenic acid ~20–80mg/100g dry weight; (7) Houttuynin (sodium houttuyfonate, synthetic analog of decanoyl acetaldehyde) — used in standardized extracts; (8) Aristolactam alkaloids — present in trace amounts, toxicological significance under investigation; (9) Essential oil constituents including methyl-n-nonyl ketone, lauryl aldehyde, and capric acid (~0.05–0.08% of fresh plant). Bioavailability Notes: Flavonoid glycosides (quercitrin, rutin) require intestinal microbial hydrolysis for absorption, limiting systemic bioavailability to approximately 15–30%; Vitamin C content degrades significantly with heat processing (>50% loss upon cooking); Decanoyl acetaldehyde is highly volatile and largely lost during drying or cooking, meaning standardized extracts (houttuyfonate) are used in clinical/research contexts to ensure consistent dosing; Heavy metal accumulation potential exists if grown in contaminated soils, warranting sourcing consideration.
Heartleaf's quercetin and chlorogenic acid inhibit the NF-κB signaling pathway, reducing transcription of inflammatory genes. The compounds suppress proinflammatory cytokines including TNF-α, IL-8, and IL-1β through direct enzyme inhibition. Additionally, these bioactives interfere with viral replication by blocking NF-κB-dependent viral transcription processes.
Current evidence for heartleaf comes primarily from preclinical studies rather than human trials. Cell culture studies demonstrate significant suppression of proinflammatory cytokines, while in vitro antiviral studies show inhibition of HSV-2 replication. Mouse respiratory studies indicate potential benefits, though sample sizes and study durations remain limited. Human clinical data is lacking, making therapeutic efficacy claims premature.
Heartleaf is generally well-tolerated but may cause gastrointestinal upset in sensitive individuals. The herb may interact with anticoagulant medications due to its anti-inflammatory properties. Pregnant and breastfeeding women should avoid heartleaf due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use, as immune system modulation effects are not fully characterized.
